Adverum Biotechnologies
ADVM
ADVM was delisted on the 8th of December, 2025.
76 hedge funds and large institutions have $153M invested in Adverum Biotechnologies in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 25 closing their positions.
6% more capital invested
Capital invested by funds: $144M → $153M (+$9.31M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 26
7.86% less ownership
Funds ownership: 67.69% → 59.83% (-7.9%)
17% less funds holding
Funds holding: 92 → 76 (-16)
28% less call options, than puts
Call options by funds: $1.57M | Put options by funds: $2.18M
60% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$3.97M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$3.19M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.7M |
| 4 |
Millennium Management
New York
|
+$1.33M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$6.36M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.33M |
| 3 |
AC
Ascend Capital
Orinda,
California
|
-$2.96M |
| 4 |
VM
VHCP Management
New York
|
-$2.46M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$2.31M |
ADVM Hedge Fund Activity: Q4 2015 in Review
76 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q4 2015, worth a combined $153M — up 6.5% from $144M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of ADVM and 10 opened new positions — a net loss of 15 holders — while 26 trimmed existing stakes and 26 added.
The largest buyer was Numeric Investors, adding an estimated $3.97M. The largest seller was Redmile Group, cutting an estimated $6.36M.
- 76 institutional investors held Adverum Biotechnologies (ADVM) as of Q4 2015, down from 92 in Q3 2015.
- Funds reported $153M of Adverum Biotechnologies stock for Q4 2015, up 6.5% quarter-over-quarter.
- 10 funds opened new Adverum Biotechnologies positions in Q4 2015 and 25 closed out, a net change of -15 holders.
- The largest Adverum Biotechnologies buyer in Q4 2015 was Numeric Investors, an estimated $3.97M added.
- The largest Adverum Biotechnologies seller in Q4 2015 was Redmile Group, an estimated $6.36M sold.
Based on aggregated 13F filings for Q4 2015.